Skip to main content

Contact


Contact Us
Give Us The Scoop
Do you have relevant medical information, firsthand account, information or photos about some content to pass along to our editors?
Pitch Biotb Personal
Fill the contact form for more information on what we're looking for and how to pitch us.
Report A Correction Or Typo
To ensure that the correct editors are notified as soon as possible, please mark the subject as "Report Corrections" in the form or comment at the bottom of the appropriate article. If the correction does not relate to a specific article, please contact via form on this site.
Have A Problem?
For customer support, please fill the form
Make A Suggestion
Leave feedback and ideas for how we can improve via contact form.
Contact to discuss advertising and custom solutions.
Get The Latest Announcements
Visit the site regularly.

Press Inquiries
Contact via form if you are a member of the press seeking information about Biotb.

Rights & Permissions
Contact via form to obtain republishing rights for original Biotb articles or videos.



Comments

Post a Comment

Popular posts from this blog

Clinical Trial for New Corona Virus Approved for Hydroxychloroquine in US

Hydroxychloroquine clinical trial for new coronary pneumonia approved in the US by the US-FDA According to a recent report from the US Newsweek website, Novartis Pharmaceuticals, headquartered in Switzerland, said it has reached an agreement with the US Food and Drug Administration to launch a new anti-malarial drug hydroxychloroquine treatment in the United States Clinical trials of hospitalized patients with pneumonia. The entire trial involved 400 patients to assess the effectiveness of the drug. According to the US Centers for Disease Control and Prevention, there are currently no effective therapies and vaccines that can cure new coronary pneumonia. In recent weeks, a number of clinical tests have been conducted around the world to determine whether hydroxychloroquine can relieve some symptoms of new coronary pneumonia, but the results obtained are very different. US President Donald Trump previously said in a White House briefing and Twitter that the drug has...
Post a Comment
Read more

ECHO Virus Cause Transmission Diagnosis and Treatment

Cause Transmission Diagnosis and Treatment of ECHO virus    ECHO virus is an abbreviation for enteric cytopathic human orphan virus. It was called orphan virus because it was unknown when it was first isolated in 1950. Name:    Echovirus Nature:    RNA virus Multiple seasons:    Summer, autumn way for spreading:    Mouth-fecal transmission Diagnosis method:    Virus culture and serology Called:     Orphan virus Harm:     ECHO virus can cause many diseases in humans Table Of Contents What harm can ECHO Virus cause? ECHO virus can cause a variety of diseases in humans, from mild respiratory infections to group B virus-induced myocarditis, pericarditis, meningoencephalitis, and severe infant systemic diseases.  Biological traits Coxsackie virus is similar to polio virus in morphology, physical an...
Post a Comment
Read more

Rumor of the US Version of Coronavirus is very popular

Rumors of the US Version of Corona virus  The rumor of the US version of the new crown is very popular. Recently, there have been a lot of wonderful ideas related to the prevention and treatment of new coronary pneumonia in the United States. Some communicators still have a medical background, seriously telling their scientific basis.     These rumors have made the US government, the US Food and Drug Administration (FDA) and other agencies panic. They have started various "counterfeiting" activities on the official website. Next, we take a look at the rumors that are circulating in the United States. 6 US version new crown rumors Rumor 1: Drinking "Yiquan Tangli Water" containing "quinine" can prevent new coronary pneumonia The so-called tonic water is a transliteration of Tonic Water, also known as tonic water and Tongning soda. It is flavored with Quinine (also known as cinchona) as the main spice, with a natural bitter tast...
Post a Comment
Read more